<DOC>
	<DOCNO>NCT02234713</DOCNO>
	<brief_summary>Disease modify therapy ( DMT ) widely use child adolescent MS . Nonetheless , many pediatric patient continue relapse therefore require change therapy . We design research study learn medication use child adolescent MS. We also interest learn behavioral feedback intervention tell u adherence medicine . Finally , hope research project inform way provide clinical care child adolescent MS .</brief_summary>
	<brief_title>Adherence Pediatric Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<criteria>Adolescent boys/girls 10 17 year 11 month old ; Have diagnosis MS , per revise McDonald diagnostic criterion International Pediatric MS Study Group criterion ; Prescribed oral injectable diseasemodifying therapy MS least six month . Have nonspecific white matter abnormality metabolic infectious etiology white matter abnormality . This indicative true diagnosis MS . Patients IV DMT include study . NonEnglish speaking patient</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>